Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

NCT00975000 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Allograft Nephropathy
Chronic Kidney Disease
Chronic Renal Failure
Disordered Mineral Metabolism
End Stage Renal Disease
Hyperparathyroidism
Hypophosphatemia
Kidney Disease
Kidney Transplantation
Post Renal Transplantation

Interventions

DRUG: Cinacalcet
DRUG: Placebo

Sponsor

Amgen